1. Incidence, Risk Factors, and Prognosis of Tricuspid Regurgitation After Cardiac Implantable Electronic Device Implantation: A Systematic Review and Meta-analysis
- Author
-
Meng Wei, Zu Kela Tu-Erhong, Ran Xiang, Jianghua Zhang, Ling Zhang, Yaodong Li, Baopeng Tang, Xianhui Zhou, Xiao-Xue Zhang, Qiang Xing, and Yanmei Lu
- Subjects
Pacemaker, Artificial ,medicine.medical_specialty ,Regurgitation (circulation) ,030204 cardiovascular system & hematology ,Cochrane Library ,Ventricular Function, Left ,law.invention ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,Risk Factors ,030202 anesthesiology ,law ,Internal medicine ,Humans ,Medicine ,Retrospective Studies ,business.industry ,Incidence ,Incidence (epidemiology) ,Hazard ratio ,Stroke Volume ,Prognosis ,Tricuspid Valve Insufficiency ,Confidence interval ,Defibrillators, Implantable ,Anesthesiology and Pain Medicine ,Meta-analysis ,Observational study ,Electronics ,Cardiology and Cardiovascular Medicine ,business - Abstract
This study aimed to determine the pooled incidence, risk factors, and clinical prognosis of tricuspid regurgitation (TR) deterioration after implantation of a cardiac implantable electronic device (CIED). The study was designed as a meta-analysis of randomized controlled trials and observational studies. Patients with indications for CIEDs were selected as participants and CIED implantation was the intervention. PubMed, EMBASE, the Cochrane Library, China National Knowledge Infrastructure, Wanfang Data, and China Science and Technology Journal Database were searched systematically to identify studies. Thirty-seven studies with 8,144 patients were included. The pooled incidence of TR deterioration of at least one grade was 25.1% (95% confidence interval [CI], 20.9-29.3; Z = 11.60; p one year after pacemaker implantation) was higher in patients with TR deterioration (hazard ratio, 1.598; 95% CI, 1.275-2.002; Z = 4.07; p
- Published
- 2022
- Full Text
- View/download PDF